Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,093 AUD | -2,11% | +1,09% | -35,86% |
Omzet 2024 * | 10,87 mln. 6,98 mln. 6,55 mln. | Omzet 2025 * | 19,14 mln. 12,3 mln. 11,52 mln. | Marktkapitalisatie | 188 mln. 121 mln. 113 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -21 mln. -13,49 mln. -12,65 mln. | Nettowinst (verlies) 2025 * | -14 mln. -9 mln. -8,43 mln. | EV/omzet 2024 * | 15 x |
Nettoliquiditeiten 2024 * | 24,71 mln. 15,87 mln. 14,88 mln. | Nettoliquiditeiten 2025 * | 13,87 mln. 8,91 mln. 8,35 mln. | EV/omzet 2025 * | 9,11 x |
K/w-verhouding 2024 * |
-9,95
x | K/w-verhouding 2025 * |
-15,6
x | Werknemers | 76 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 85,74% |
Recentste transcriptie over ImpediMed Limited
1 dag | -2,11% | ||
1 week | +1,09% | ||
Lopende maand | +1,09% | ||
1 maand | -5,10% | ||
3 maanden | -31,11% | ||
6 maanden | -28,46% | ||
Lopend jaar | -35,86% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Parmjot Bains
CEO | Chief Executive Officer | - | 08/01 |
McGregor Grant
DFI | Director of Finance/CFO | - | 28-09-23 |
Steven Chen
CTO | Chief Tech/Sci/R&D Officer | - | 26-09-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Parmjot Bains
CEO | Chief Executive Officer | - | 08/01 |
McGregor Grant
DFI | Director of Finance/CFO | - | 28-09-23 |
Chairman | - | 28-09-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 0,093 | -2,11% | 1 210 425 |
18-04-24 | 0,095 | +1,06% | 1 334 047 |
17-04-24 | 0,094 | 0,00% | 4 733 796 |
16-04-24 | 0,094 | +5,62% | 2 455 687 |
15-04-24 | 0,089 | -3,26% | 473 132 |
uitgestelde koers Australian S.E., 19 april 2024 om 07:59 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-35,86% | 124 mln. | |
+2,37% | 207 mld. | |
+1,73% | 175 mld. | |
+8,72% | 132 mld. | |
+16,55% | 99,1 mld. | |
-3,50% | 60,89 mld. | |
+12,79% | 52,04 mld. | |
-6,33% | 45,48 mld. | |
-4,13% | 38,81 mld. | |
+9,51% | 38,77 mld. |